Core Laboratories Inc (NYSE: CLB) kicked off on Tuesday, up 3.73% from the previous trading day, before settling in for the closing price of $11.52. Over the past 52 weeks, CLB has traded in a range of $10.14-$25.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Energy Sector giant was -20.53%. While this was happening, its average annual earnings per share was recorded -17.23%. With a float of $46.36 million, this company’s outstanding shares have now reached $46.70 million.
Let’s determine the extent of company efficiency that accounts for 3500 employees. In terms of profitability, gross margin is 16.91%, operating margin of 10.04%, and the pretax margin is 8.28%.
Core Laboratories Inc (CLB) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Oil & Gas Equipment & Services Industry. The insider ownership of Core Laboratories Inc is 1.12%, while institutional ownership is 113.85%.
Core Laboratories Inc (CLB) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -17.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.35% during the next five years compared to -20.53% drop over the previous five years of trading.
Core Laboratories Inc (NYSE: CLB) Trading Performance Indicators
Take a look at Core Laboratories Inc’s (CLB) current performance indicators. Last quarter, stock had a quick ratio of 1.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.08. Likewise, its price to free cash flow for the trailing twelve months is 12.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.59, a number that is poised to hit 0.19 in the next quarter and is forecasted to reach 0.83 in one year’s time.
Technical Analysis of Core Laboratories Inc (CLB)
Looking closely at Core Laboratories Inc (NYSE: CLB), its last 5-days average volume was 0.79 million, which is a jump from its year-to-date volume of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 26.46%.
During the past 100 days, Core Laboratories Inc’s (CLB) raw stochastic average was set at 22.33%, which indicates a significant decrease from 38.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.48% in the past 14 days, which was lower than the 61.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.68, while its 200-day Moving Average is $16.12. However, in the short run, Core Laboratories Inc’s stock first resistance to watch stands at $12.35. Second resistance stands at $12.75. The third major resistance level sits at $13.28. If the price goes on to break the first support level at $11.41, it is likely to go to the next support level at $10.88. Now, if the price goes above the second support level, the third support stands at $10.48.
Core Laboratories Inc (NYSE: CLB) Key Stats
The company with the Market Capitalisation of 560.25 million has total of 46,883K Shares Outstanding. Its annual sales at the moment are 523,850 K in contrast with the sum of 31,400 K annual income. Company’s last quarter sales were recorded 123,590 K and last quarter income was -150 K.
